Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC AER-271 10mM 1mL | 634913-39-6 | 463.65 g/mol | C15H9ClF6NO5P | 1 ML
Supplier: Medchemexpress LLC HY11546010MM 1ML
AER-271 is a phosphonate prodrug derivative that selectively inhibits aquaporin-4 (AQP4). Converted in vivo to the active AQP4 antagonist by endogenous phosphatases, it has increased aqueous solubility and is used in preclinical research to prevent early cerebral edema after ischemic or asphyxial injury.
- Selective aquaporin-4 (AQP4) inhibitor for preclinical research.
- Phosphonate prodrug design increases water solubility versus the parent compound.
- Shown to reduce early cerebral edema and improve early neurological outcome in animal models.
- Available as a 10 mM solution in DMSO (1 mL) and in multiple solid pack sizes for experimental use.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?